◆ Implementation period: October 1, 2025 to November 30, 2025

◆Respondents: Japan Pharmaceutical Manufacturers Association/Japan PDA Pharmaceutical Association/Japan Generic Medicines Association

 

[ Goals of this survey]

① Survey on awareness of "pharmaceutical DX" by pharmaceutical company and department nationwide

(What are the expectations by region and department? Data collection/visualization)

② Clarifying priority issues in promoting pharmaceutical DX within companies

(Identifying issues from management, technology, and business perspectives (inefficient operations))

③To-be: Understanding the needs as they should be

(Understanding needs for what should be done with IT and DX to improve the workplace)